SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $79,000 | -64.3% | 16,892 | -41.6% | 0.00% | – |
Q3 2021 | $221,000 | -68.7% | 28,930 | -60.3% | 0.00% | -100.0% |
Q2 2021 | $707,000 | -38.2% | 72,941 | -47.3% | 0.00% | -50.0% |
Q1 2021 | $1,144,000 | +38.7% | 138,284 | +14.4% | 0.00% | +100.0% |
Q4 2020 | $825,000 | -43.1% | 120,911 | -7.1% | 0.00% | -50.0% |
Q3 2020 | $1,451,000 | +514.8% | 130,119 | +246.2% | 0.00% | – |
Q2 2020 | $236,000 | +345.3% | 37,589 | +31.0% | 0.00% | – |
Q1 2020 | $53,000 | +1.9% | 28,692 | +163.9% | 0.00% | – |
Q1 2019 | $52,000 | -86.3% | 10,873 | -93.1% | 0.00% | – |
Q4 2018 | $380,000 | -67.4% | 158,496 | -40.1% | 0.00% | -100.0% |
Q3 2018 | $1,164,000 | -0.9% | 264,658 | +62.2% | 0.00% | 0.0% |
Q2 2018 | $1,174,000 | +8.3% | 163,120 | +31.1% | 0.00% | -50.0% |
Q4 2015 | $1,084,000 | +6.1% | 124,448 | +2.1% | 0.00% | 0.0% |
Q3 2015 | $1,022,000 | +846.3% | 121,831 | +1038.6% | 0.00% | – |
Q4 2014 | $108,000 | +52.1% | 10,700 | -32.3% | 0.00% | – |
Q3 2014 | $71,000 | -36.6% | 15,800 | -4.8% | 0.00% | – |
Q2 2014 | $112,000 | – | 16,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
EMFO, LLC | 209,398 | $185,527 | 0.19% |
Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
Mayo Clinic | 300,000 | $267,000 | 0.14% |
swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |